Morgan Stanley Mimedx Group, Inc. Transaction History

Morgan Stanley

$1.35 Trillion
Q3 2024

A detailed history of Morgan Stanley transactions in Mimedx Group, Inc. stock. As of the latest transaction made, Morgan Stanley holds 1,150,048 shares of MDXG stock, worth $10.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,150,048

Previous 1,326,910 13.33%

Holding current value

$10.7 Million

Previous $9.2 Million 26.09%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$5.65 - $7.76 $999,270 - $1.37 Million	-176,862 Reduced 13.33%	1,150,048 $6.8 Million
Q2 2024 Oct 17, 2024	SELL	$6.16 - $8.08 $3.71 Million - $4.86 Million	-601,658 Reduced 31.2%	1,326,910 $9.2 Million
Q2 2024 Aug 14, 2024	SELL	$6.16 - $8.08 $3.71 Million - $4.86 Million	-601,658 Reduced 31.2%	1,326,910 $9.2 Million
Q1 2024 Oct 17, 2024	BUY	$7.61 - $8.63 $4.58 Million - $5.19 Million	601,658 Added 45.34%	1,928,568 $14.8 Million
Q1 2024 Aug 16, 2024	BUY	$7.61 - $8.63 $2.59 Million - $2.94 Million	340,975 Added 21.48%	1,928,568 $14.8 Million
Q1 2024 May 15, 2024	BUY	$7.61 - $8.63 $2.59 Million - $2.94 Million	340,975 Added 21.48%	1,928,568 $14.8 Million
Q4 2023 Aug 16, 2024	BUY	$5.7 - $9.14 $1.49 Million - $2.38 Million	260,683 Added 19.65%	1,587,593 $13.9 Million
Q4 2023 Feb 13, 2024	BUY	$5.7 - $9.14 $58,482 - $93,776	10,260 Added 0.65%	1,587,593 $13.9 Million
Q3 2023 Nov 15, 2023	BUY	$6.35 - $8.16 $2.03 Million - $2.6 Million	319,079 Added 25.36%	1,577,333 $11.5 Million
Q2 2023 Aug 14, 2023	BUY	$3.14 - $6.61 $2.54 Million - $5.36 Million	810,314 Added 180.9%	1,258,254 $8.32 Million
Q1 2023 May 15, 2023	BUY	$2.97 - $4.81 $743,459 - $1.2 Million	250,323 Added 126.67%	447,940 $1.53 Million
Q4 2022 Feb 14, 2023	BUY	$2.63 - $3.45 $183,595 - $240,837	69,808 Added 54.62%	197,617 $549,000
Q3 2022 Nov 14, 2022	SELL	$2.71 - $4.22 $296,644 - $461,933	-109,463 Reduced 46.13%	127,809 $367,000
Q2 2022 Oct 27, 2022	SELL	$3.17 - $5.0 $116,291 - $183,425	-36,685 Reduced 13.39%	237,272 $823,000
Q2 2022 Aug 15, 2022	SELL	$3.17 - $5.0 $116,291 - $183,425	-36,685 Reduced 13.39%	237,272 $823,000
Q1 2022 Oct 27, 2022	BUY	$4.27 - $6.27 $156,644 - $230,014	36,685 Added 15.46%	273,957 $1.29 Million
Q1 2022 May 13, 2022	BUY	$4.27 - $6.27 $517,267 - $759,547	121,140 Added 79.27%	273,957 $1.29 Million
Q4 2021 Feb 14, 2022	BUY	$5.7 - $8.48 $23,712 - $35,276	4,160 Added 2.8%	152,817 $922,000
Q3 2021 Nov 15, 2021	BUY	$5.52 - $15.83 $820,586 - $2.35 Million	148,657 New	148,657 $901,000

Others Institutions Holding MDXG

# of Institutions

209

Shares Held

98.2M

Call Options Held

Put Options Held

65.3K

View Full List

About MIMEDX GROUP, INC.

Ticker MDXG
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 113,609,000
Market Cap $1.05B
Description
MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary pr...

More about MDXG

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account